One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: A prospective controlled study

BJU International

Volumn 98, Issue 5, 2006, Pages 1075-1079

  Mariappan, Paramananthan ^a   Smith, Gordon ^a   Moussa, Sami A ^a   Tolley, David A ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Controlled study; Percutaneous nephrolithotomy; Systemic inflammatory response syndrome; Urine culture and sensitivity; Urosepsis

Indexed keywords

CIPROFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE TIME EFFECT RELATION; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION RISK; INTRAVENOUS UROGRAPHY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NEPHROLITHOTOMY; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINALYSIS; URINARY TRACT INFECTION; UROLITHIASIS; UROSEPSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DILATATION, PATHOLOGIC; FEMALE; HUMANS; KIDNEY CALCULI; LITHOTRIPSY; MALE; MIDDLE AGED; NEPHROSTOMY, PERCUTANEOUS; PROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 33749551473     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06450.x     Document Type: Article

References (15)

1. O'Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 1993; 72: 277-83
2. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 1991; 146: 955-60
3. Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 2005; 173: 1610-4
4. Bratell S, Brorson JE, Grenabo L, Hedelin H, Pettersson S. The bacteriology of operated renal stones. Eur Urol 1990; 17: 58-61
5. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46: 94-100
6. European Association of Urology (EAU). Guidelines on Urinary and Male Genital Tract Infections 2001. Available at: http://www.uroweb.nl/files/ uploaded_files/2001_URINARY_AND_MALE_GENITAL_TRACT_INFECTIONS.PDF. Accessed June 2006
7. McAleer IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP. Endotoxin content in renal calculi. J Urol 2003; 169: 1813-4
8. Nemoy NJ, Stamey TA. Surgical, bacteriological and biochemical management of 'infection stones'. JAMA 1971; 215: 1470-6
9. Fowler JE Jr. Bacteriology of branched renal calculi and accompanying urinary tract infection. J Urol 1984; 131: 213-5
10. McCartney AC, Clark J, Lewi HJ. Bacteriological study of renal calculi. Eur J Clin Microbiol 1985; 4: 553-5
11. Mariappan P, Loong CW. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteric stone or infected stones. J Urol 2004; 171: 2142-5
12. Shigeta M, Hayashi M, Igawa M. A clinical study of upper urinary tract calculi treated with extracorporeal shock wave lithotripsy: association with bacteriuria before treatment. Urol Int 1995; 54: 214-6
13. Gault MH, Longerich LL, Crane G et al. Bacteriology of urinary tract stones. J Urol 1995; 153: 1164-70
14. Segura JW, Preminger GM, Assimos DG et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol 1994; 151: 1648-51
15. Anonymous. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74